MedPath

Effect of Aging on Haemostasis Parameters

Completed
Conditions
Aging
Registration Number
NCT00299624
Lead Sponsor
Hopital Lariboisière
Brief Summary

Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.

Detailed Description

Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolysis and microparticles measurement.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • age <40 2 groups : 1 : no history of VTE 2 : history of VTE
Exclusion Criteria
  • antiaggregant or anticoagulant therapy at curative dose
  • arterial or thrombotic event in the last month

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Hopital Lariboisière

🇫🇷

Paris, France

Hopital Lariboisiere

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath